In financial year 2022, Hyphens Pharma International Limited reported revenue of 162.3 million Singapore dollars, a significant increase compared to the previous financial year. Hyphens Pharma International is a Singapore-based specialty pharmaceutical and consumer healthcare group operating in Southeast Asian countries.
Revenue of Hyphens Pharma International Limited from financial years 2016 to 2022 (in million Singapore dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Pharmaceutical companies with highest ad expenditure in Poland 2022-2023
- Premium Statistic E-commerce share in pharmacy sales in Russia 2023, by product
- Basic Statistic Number of applications for clinical trials in Norway 2008-2021
- Basic Statistic Leading pharmaceutical companies in Norway 2021, by revenue
- Basic Statistic Sales value of nonprescription pharmaceuticals in Norway 2017-2021
- Basic Statistic Largest nonprescription pharmaceutical companies in Norway 2021, by market share
- Premium Statistic Domestic partnership deals in China's pharma industry 2013-2021
- Premium Statistic Foreign partnership in China's pharma industry 2013-2021
- Premium Statistic R&D employees of the pharmaceutical company Chiesi 2020, by country
- Premium Statistic Key pharmaceutical brands produced by Chiesi 2016-2019, by revenue
About the region
10
- Premium Statistic Value added by the pharmaceutical industry Singapore 2014-2023
- Premium Statistic Number of employees in the pharmaceutical industry Singapore 2000-2023
- Premium Statistic Value added per worker in the pharmaceutical industry Singapore 2000-2023
- Premium Statistic Revenue of the hand sanitizer industry in Singapore 2018-2029
- Premium Statistic Revenue of the analgesics industry in Singapore 2018-2029
- Premium Statistic Revenue of the cold & cough remedies industry in Singapore 2018-2029
- Premium Statistic Revenue of the digestives & intestinal remedies industry in Singapore 2018-2029
- Premium Statistic Revenue of the skin treatment industry in Singapore 2018-2029
- Premium Statistic Revenue of the OTC pharmaceuticals industry in Singapore 2018-2029
- Premium Statistic Revenue of the vitamins & minerals industry in Singapore 2018-2029
Selected statistics
10
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Merck & Co total assets 2009-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Premium Statistic Global pharmaceutical pipeline by therapy area 2013-2017
- Premium Statistic U.S. branded prescription revenue forecast 2009-2015
Other regions
10
- Basic Statistic Number of applications for drug reimbursement in Denmark 2013-2022
- Premium Statistic Total savings of top generic drugs in U.S. 2022
- Basic Statistic Number of public pharmacies in the Netherlands 2017-2023
- Basic Statistic Revenue of pharmaceutical company Recordati 2022, by product
- Premium Statistic US and European private VC-backed orphan biopharma company M&A values 2014-2019
- Premium Statistic Colombia: pharmaceutical establishments 2014-2018
- Premium Statistic Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Premium Statistic Italy: number of R&D employees of biotech pharma companies 2014-2017
- Premium Statistic Most downloaded pharmacy apps in Russia 2023
- Basic Statistic Washington D.C.'s medical cannabis spending 2018-2024
Related statistics
10
- Premium Statistic Import value of pharmaceutical products Singapore 2013-2022
- Premium Statistic Export value of vaccines for human medicine Singapore 2012-2021
- Premium Statistic Import value of vaccines for human medicine Singapore 2012-2021
- Premium Statistic Export value of medicaments Singapore 2013-2022
- Premium Statistic Import value of medicaments Singapore 2013-2022
- Premium Statistic Export value of pharmaceutical products Singapore 2013-2022
- Premium Statistic Number of licenses for health product importers approved Singapore 2017-2022
- Premium Statistic Number of licenses for health product exporters approved Singapore 2017-2023
- Premium Statistic Number of licenses for health product wholesalers approved Singapore 2017-2022
- Premium Statistic Number of clinical trials approved Singapore 2017-2023
Further related statistics
10
- M&A capacities - changes for the global pharma industry 2008-2015
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Celgene's revenue and net income 2006-2018
- Net revenue from investment banking at Goldman Sachs 2009-2023
- Pfizer's ad spending 2006-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Annual revenue of Sinopharm 2010-2022
- Revenue of Sinopharm 2011-2022, by category
Further Content: You might find this interesting as well
Statistics
- M&A capacities - changes for the global pharma industry 2008-2015
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Celgene's revenue and net income 2006-2018
- Net revenue from investment banking at Goldman Sachs 2009-2023
- Pfizer's ad spending 2006-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Annual revenue of Sinopharm 2010-2022
- Revenue of Sinopharm 2011-2022, by category
Hyphens Pharma International. (April 5, 2023). Revenue of Hyphens Pharma International Limited from financial years 2016 to 2022 (in million Singapore dollars) [Graph]. In Statista. Retrieved May 16, 2024, from https://www.statista.com/statistics/1197464/hyphens-pharma-revenue/
Hyphens Pharma International. "Revenue of Hyphens Pharma International Limited from financial years 2016 to 2022 (in million Singapore dollars)." Chart. April 5, 2023. Statista. Accessed May 16, 2024. https://www.statista.com/statistics/1197464/hyphens-pharma-revenue/
Hyphens Pharma International. (2023). Revenue of Hyphens Pharma International Limited from financial years 2016 to 2022 (in million Singapore dollars). Statista. Statista Inc.. Accessed: May 16, 2024. https://www.statista.com/statistics/1197464/hyphens-pharma-revenue/
Hyphens Pharma International. "Revenue of Hyphens Pharma International Limited from Financial Years 2016 to 2022 (in Million Singapore Dollars)." Statista, Statista Inc., 5 Apr 2023, https://www.statista.com/statistics/1197464/hyphens-pharma-revenue/
Hyphens Pharma International, Revenue of Hyphens Pharma International Limited from financial years 2016 to 2022 (in million Singapore dollars) Statista, https://www.statista.com/statistics/1197464/hyphens-pharma-revenue/ (last visited May 16, 2024)
Revenue of Hyphens Pharma International Limited from financial years 2016 to 2022 (in million Singapore dollars) [Graph], Hyphens Pharma International, April 5, 2023. [Online]. Available: https://www.statista.com/statistics/1197464/hyphens-pharma-revenue/